College of Medicine
http://hdl.handle.net/10576/42
2024-03-28T12:26:56ZCorrigendum to “Morphometric study of the facial skeleton in Jordanians: A computed tomography scan-based study” [Forensic Sci. Int. 302 (2019) 109916] (Forensic Science International (2019) 302, (S0379073819303287), (10.1016/j.forsciint.2019.109916))
http://hdl.handle.net/10576/53711
Corrigendum to “Morphometric study of the facial skeleton in Jordanians: A computed tomography scan-based study” [Forensic Sci. Int. 302 (2019) 109916] (Forensic Science International (2019) 302, (S0379073819303287), (10.1016/j.forsciint.2019.109916))
Mustafa, Ayman; Abusamra, Heba; Kanaan, Nadeem; Alsalem, Mohammad; Allouh, Mohammed; Kalbouneh, Heba
The authors regret that the affiliation published for Dr. Mohammed Allouh and Heba شis incorrect. The affiliation for Dr. Mohammed Allouh should be: Faculty of Medicine, Jordan University of Science and Technology, Irbid, 22110, Jordan. The authors would like to apologise for any inconvenience caused.
2020-10-01T00:00:00ZErratum: Software Intervention in Smoking Cessation among Engineering Students in Bhubaneswar City: A Randomized Controlled Trial
http://hdl.handle.net/10576/53637
Erratum: Software Intervention in Smoking Cessation among Engineering Students in Bhubaneswar City: A Randomized Controlled Trial
Rajagopal, Padma M.; Sil, Satyam; Dinesh, Prameela; Shiju, Shilpa; Arunkumar, D. P.; Ramaiah, Srinivas S.; Lalitha, Hande R.; Mamatha, T.; Kantinath, Ainapure P.; Pujari, Lokesh; Pradeep, B. S.; Shenoy, Anusha B.; Desai, Anita; Munivenkatappa, Ashok; Gudi, Chetan S.; Babu, Giridhara R.; Sudarshan, M. K.
In the article titled “Assessing the Burden of COVID-19 among Children Aged 6-14 Years in Karnataka, India: A Cross-sectional Survey”, by Padma M Rajagopal, Satyam Sil, Prameela Dinesh, Shilpa Shiju, Arunkumar D P, Srinivas S Ramaiah, Hande Lalitha R, Mamatha T, Ainapure Kantinath P, Lokesh Pujari, Pradeep BS, Anusha B Shenoy, Anita Desai, Ashok Munivenkatappa, Chetan S Gudi, Giridhara R Babu, M K Sudarshan, published on pages 110-114, Issue 1, Volume 49 of Indian Journal of Community Medicine.
One of the authors Dr. Giridhara R Babu affiliation was mentioned incorrectly.
The correct affiliation of Dr. Giridhara R Babu should be read as mentioned below
Professor of Global Health, College of Medicine, QU Health, Qatar University, Doha, Qatar.
2024-01-01T00:00:00ZAssessing the Burden of COVID‑19 among Children Aged 6‑14 Years in Karnataka, India: A Cross‑sectional Survey
http://hdl.handle.net/10576/53636
Assessing the Burden of COVID‑19 among Children Aged 6‑14 Years in Karnataka, India: A Cross‑sectional Survey
Rajagopal, Padma M.; Sil, Satyam; Dinesh, Prameela; Shiju, Shilpa; Arunkumar, D. P.; Ramaiah, Srinivas S.; Lalitha, Hande R.; Mamatha, T.; Kantinath, Ainapure P.; Pujari, Lokesh; Pradeep, B. S.; Shenoy, Anusha B.; Desai, Anita; Munivenkatappa, Ashok; Gudi, Chetan S.; Babu, Giridhara R.; Sudarshan, M. K.
Background: India experienced three coronavirus disease (COVID-19) waves, with the third attributed to the highly contagious Omicron variant. Before the national vaccination rollout for children above 6, understanding severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) positivity in the pediatric population was essential. This study aims to assess the burden of Covid-19 infection and to estimate the seroprevalence in children aged 6 to 14 years in the state of Karnataka. Material and Methods: We surveyed 5,358 children aged 6-14 across Karnataka using 232 health facilities, from June 6 to 14, 2022. We determined the sample size using the PPS (Population Proportional to Size) technique and employed cluster sampling. We tested all participants for SARS-CoV-2 IgG with an enzyme-linked immunosorbent assay (ELISA) kit and SARS-CoV-2 RNA with reverse transcription-polymerase chain reaction (RT-PCR). We sequenced samples with a cycle threshold (CT) value below 25 using whole genomic sequencing (WGS). Result: We found an adjusted seroprevalence of IgG at 75.38% statewide, and we found 0.04% of children RT-PCR positive for COVID-19. We determined a case-to-infection ratio of 1:37 and identified the SARS-CoV-2 strains as Omicron, BA.5, and BA.2.10. Conclusion: The study showed a high seroprevalence of IgG among children with low active infection. Omicron, BA. 5, and BA. 2.10 variants were detected through WGS.
2024-01-01T00:00:00ZForging the Path to Precision Medicine in Qatar: A Public Health Perspective on Pharmacogenomics Initiatives
http://hdl.handle.net/10576/53373
Forging the Path to Precision Medicine in Qatar: A Public Health Perspective on Pharmacogenomics Initiatives
Bastaki, Kholoud; Velayutham, Dinesh; Irfan, Areeba; Adnan, Mohd; Mohammed, Sawsan; Mbarek, Hamdi; Qoronfleh, Walid; Jithesh, Puthen Veettil
Pharmacogenomics (PGx) is an important component of precision medicine that promises tailored treatment approaches based on an individual’s genetic information. Exploring the initiatives in research that help to integrate PGx test into clinical setting, identifying the potential barriers and challenges as well as planning the future directions, are all important for fruitful PGx implementation in any population. Qatar serves as an exemplar case study for the Middle East, having a small native population compared to a diverse immigrant population, advanced healthcare system, national genome program, and several educational initiatives on PGx and precision medicine. This paper attempts to outline the current state of PGx research and implementation in Qatar within the global context, emphasizing ongoing initiatives and educational efforts. The inclusion of PGx in university curricula and healthcare provider training, alongside precision medicine conferences, showcase Qatar’s commitment to advancing this field. However, challenges persist, including the requirement for population specific implementation strategies, complex genetic data interpretation, lack of standardization, and limited awareness. The review suggests policy development for future directions in continued research investment, conducting clinical trials for the feasibility of PGx implementation, ethical considerations, technological advancements, and global collaborations to overcome these barriers.
2024-03-18T00:00:00Z